Medigene AG: Medigene adjusts 2020 financial guidance and expects improved EBITDA result

ID: 1558398
recent pressrelease next pressrelease

(businesspress24) - Public disclosure of inside information according to article 17 MAR

Martinsried/Munich (27.05.2020) - 27 May 2020. The Executive Board of Medigene AG (Medigene, FSE: MDG1, Prime Standard) today decided to adjust its previous 2020 full-year guidance with lower research and development expenses resulting in improved earnings before interest, taxes, depreciation, and amortization (EBITDA).

Medigene''s core development programs continue despite the ongoing COVID-19 pandemic. Total revenue guidance remains unchanged at EUR 7 - 9 m. Previous guidance for research and development expenses was based on certain conservative assumptions. However, with the experience of the past months, additional operating efficiencies, and the goal to extend the cash runway through cost savings as a cautionary measure during COVID-19 times, Medigene''s guidance for research and development expenses is hereby reduced to the range of Eur24 - 29 m (previously Eur29 - 34 m). Consequently, the guidance for the anticipated EBITDA loss improves to the range of Eur19 - 27 m (previously EBITDA loss of Eur24 - 32 m).

Based on this planning, the Company is financed until end of 2021.


emitter: Medigene AG
address: Lochhamer Straße 11, 82152 Planegg/Martinsried
country: Germany
contact person: Medigene PR/IR
phone: +49 89 2000 3333 01
e-mail: investor(at)

ISIN(s): DE000A1X3W00 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf, free market in Hannover; open market in Berlin, Tradegate

More information:

Keywords (optional):

Company information / Profile:

PressRelease by


Die Medigene AG ist ein börsennotiertes Biotechnologie-Unternehmen mit Hauptsitz in Martinsried bei München.

PressContact / Agency:

published by: irw
print pressrelease  send to a friend  

Date: 05/27/2020 - 12:48
Language: English
News-ID 1558398
Character count: 2589
Firma: Medigene AG
Ansprechpartner: Feedback to about Pressrelease-id:
Stadt: Wien


Number of hits: 389


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 43

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.